Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]

Gregory Lip; K Huber; F Andreotti; H Arnesen; KJ Airaksinen; T Cuisset; Paulus Kirchhof; F Marin

doi:10.1160/TH09-08-0580

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]

Gregory Lip
, K Huber
, F Andreotti
, H Arnesen
, KJ Airaksinen
, T Cuisset
, Paulus Kirchhof
, F Marin

Research output: Contribution to journal › Review article

258 Citations (Scopus)

Abstract

There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.

Original language	English
Pages (from-to)	13-28
Number of pages	16
Journal	Thrombosis and Haemostasis
Volume	103
Issue number	1
DOIs	https://doi.org/10.1160/TH09-08-0580
Publication status	Published - 1 Jan 2010

Keywords

percutaneous coronary intervention
acute coronary syndrome
warfarin
stenting
antithrombotic therapy
Arial fibrillation

Access to Document

10.1160/TH09-08-0580

Fingerprint

Dive into the research topics of 'Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]'. Together they form a unique fingerprint.

Cite this

Lip, G., Huber, K., Andreotti, F., Arnesen, H., Airaksinen, KJ., Cuisset, T., Kirchhof, P., & Marin, F. (2010). Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]. Thrombosis and Haemostasis, 103(1), 13-28. https://doi.org/10.1160/TH09-08-0580

Lip, Gregory ; Huber, K ; Andreotti, F et al. / Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]. In: Thrombosis and Haemostasis. 2010 ; Vol. 103, No. 1. pp. 13-28.

@article{f5fce559e4d04c228f4b3c71eba938b1,

title = "Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]",

abstract = "There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.",

keywords = "percutaneous coronary intervention, acute coronary syndrome, warfarin, stenting, antithrombotic therapy, Arial fibrillation",

author = "Gregory Lip and K Huber and F Andreotti and H Arnesen and KJ Airaksinen and T Cuisset and Paulus Kirchhof and F Marin",

year = "2010",

month = jan,

day = "1",

doi = "10.1160/TH09-08-0580",

language = "English",

volume = "103",

pages = "13--28",

journal = "Thrombosis and Haemostasis",

publisher = "Schattauer",

number = "1",

}

Lip, G, Huber, K, Andreotti, F, Arnesen, H, Airaksinen, KJ, Cuisset, T, Kirchhof, P & Marin, F 2010, 'Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]', Thrombosis and Haemostasis, vol. 103, no. 1, pp. 13-28. https://doi.org/10.1160/TH09-08-0580

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]. / Lip, Gregory; Huber, K; Andreotti, F et al.
In: Thrombosis and Haemostasis, Vol. 103, No. 1, 01.01.2010, p. 13-28.

Research output: Contribution to journal › Review article

TY - JOUR

T1 - Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]

AU - Lip, Gregory

AU - Huber, K

AU - Andreotti, F

AU - Arnesen, H

AU - Airaksinen, KJ

AU - Cuisset, T

AU - Kirchhof, Paulus

AU - Marin, F

PY - 2010/1/1

Y1 - 2010/1/1

N2 - There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.

AB - There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.

KW - percutaneous coronary intervention

KW - acute coronary syndrome

KW - warfarin

KW - stenting

KW - antithrombotic therapy

KW - Arial fibrillation

U2 - 10.1160/TH09-08-0580

DO - 10.1160/TH09-08-0580

M3 - Review article

C2 - 20062939

VL - 103

SP - 13

EP - 28

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

IS - 1

ER -

Lip G, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset T et al. Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]. Thrombosis and Haemostasis. 2010 Jan 1;103(1):13-28. doi: 10.1160/TH09-08-0580